Evidence capacity for challenger companies

Compete above
your headcount.

Tensorust gives challenger companies the evidence capacity of an enterprise research team. We find what larger competitors missed, connect the evidence, and produce something you can use immediately to win.

Not another AI assistant.  ·  Not a database subscription.  ·  An outsourced evidence department.
Your competitors have more analysts. They should not know more than you.
Every finding links to its original record Public and permitted sources only Limits stated, never overclaimed Free sample before you commit

The fight you are actually in

The company across from you is not smarter. It is staffed.

A larger competitor runs functions you cannot afford to hire: a market intelligence desk, regulatory affairs, a capture team, a research group. That is the real gap. Not talent, not technology. Capacity to find and reconcile evidence.

The incumbent across from you
  • A market intelligence function tracking your category full time
  • Regulatory affairs staff who read every rulemaking and standard
  • A capture team watching contract vehicles and recompetes
  • Analysts who assemble the diligence packet before the meeting
VS
You
  • Experts who are already fully committed to the product
  • No one whose job is to watch the record
  • Days lost every time a real question comes up
  • The same public evidence available to you — and no time to reach it

Tensorust connects contracts, filings, grants, patents, research, regulation and corporate records into cited intelligence that smaller teams can act on immediately.

Your experts make the judgment. Tensorust eliminates the days spent finding and reconciling the evidence.

What we build

Not research. A competitive outcome you can put in front of a buyer, a board, an agency or an investor.

Each one is a defined deliverable built from primary records, with every figure linked back to the source and the coverage limits written in.

01

Incumbent Weakness Map

Where the larger competitor is actually exposed. Contracts approaching recompete, thin or expiring patent coverage, recalls and safety findings, published security exposure, lapsed registrations, quiet retreats from a segment. Every exposure tied to the record that shows it.

Bought by founders and commercial leads who need to know where to push.
02

Market Entry Evidence Pack

What the market actually looks like before you commit to it. Who holds the contracts, which agencies and buyers are active, what the standards require, who the incumbents are, and where public money is already moving.

Bought by strategy and US expansion leads.
03

Contract Opportunity Map

Federal and institutional buying activity in your category. Who won, how much was actually obligated against the announced ceiling, when the recompete lands, and which offices buy the thing you make.

Bought by business development and capture leads.
04

Regulatory Window Monitor

The standards, rulemaking, agency programs and funding lines that open or close a window for your technology — tracked continuously, so a change reaches you while you can still act on it.

Bought by policy leads and regulated-market operators.
05

Competitor Claim Audit

Test what a competitor says in public against what the record shows. Announced contract value against dollars actually obligated. Claimed approvals against the regulatory record. Claimed scale against filings. Supported, overstated, or missing context — with the evidence attached.

Bought by product marketing and commercial teams.
06

Investor Diligence Packet

Institutional-quality diligence on a company or a sector without an institutional research operation. Assembled from primary records, with the limits stated plainly so a partner can rely on it in an investment committee.

Bought by partners and principals at smaller funds.
07

Technical Credibility Pack

The cited evidence a conservative buyer needs before adopting something new: the research base behind the technology, federal validation and funding, standards position, and comparable public deployments. Built to be handed directly to a skeptical customer.

Bought by industrial and advanced-material companies selling into cautious markets.
08

Monthly Competitive Evidence Monitor

The department that keeps running. Funding, standards, policy, contract and competitor changes in your category, delivered on a cadence, so nobody on your team loses days searching for something that moved last week.

Bought by teams who need the advantage to compound, not expire.

Who it is for

Companies for whom better information is a weapon.

The pattern is consistent: you sell into a complicated market, and you are facing a company much larger than you are.

#CustomerWhy they buyWho buys
01Industrial and advanced-material startupsThey must convince conservative buyers that new technology is credible.Founder, CEO, commercial lead
02Smaller manufacturers and government contractorsThey need to find opportunities before large incumbents dominate them.CEO, business development, capture lead
03Boutique consulting, engineering, legal and public-affairs firmsTensorust increases output without adding junior analysts.Managing partner, practice lead
04Emerging biotech, medtech and pharmaceutical companiesThey need research, FDA, grant, KOL and competitor evidence.Strategy, business development, medical affairs
05Cybersecurity challengersThey need vulnerability, contract and competitor intelligence.Founder, product marketing, federal sales
06Venture funds, search funds and smaller private-equity firmsThey need institutional-quality diligence without a massive research operation.Partner, principal, platform lead
07Foreign companies entering the United StatesThey need contracts, regulation, standards, agencies and competitor maps.US expansion lead, strategy
08New industry coalitions and challenger associationsThey need evidence and credibility before they possess institutional authority.Executive director, policy lead

The pattern. Usually between 10 and 500 employees. Selling into a complicated market — regulated, procurement-driven, standards-bound, or technically conservative. Facing a competitor with many times the staff. If that is you, the evidence you need is already public. Reaching it is the problem Tensorust solves.

What a finding looks like

One number you can act on, and the records that make it defensible.

These come from live public records. The data was already public — the advantage comes from joining the right records and knowing what the fields actually mean.

Competitor claim audit
$266M$22M
announced headline → dollars actually obligated, on the record
A competitor's biggest number, checked in one lookup.
The announced ceiling and the money actually obligated are different fields. We pull both and link the award. Run it →
Incumbent exposure
94,0001,647
reported vulnerabilities → the ones CISA lists as actively exploited
The exposure that is real, separated from the noise.
Severity tells you what could hurt. Exploitation tells you what attackers already use. One field turns a wall of findings into a short list. Run it →
Answer vs evidence
$18.1M122 filings
one usable answer → the original federal records behind it
Every amount itemized. Every filing linked.
The total moves the conversation. The source trail is what survives the pushback. Open the receipt →

Free tools

Check the work before you spend anything.
Tensorust Under Oath
Put a competitor's claim under oath.
Paste a claim, a headline, or a contract announcement. We search federal contracts, filings, lobbying and grants, then return the evidence receipt.
Open the investigator →
Public Money Radar
See what the incumbents spend to be heard.
Federal lobbying set against federal contract dollars, company by company. Useful for understanding who is shaping the rules in your category.
Open the radar →

See the work

Real source-linked packets. Open any one and inspect the citations.

These were not written as reports. Each is a prototype of an outsourced evidence department: the days of first-pass work a larger competitor's staff would have done internally, already assembled and cited.

Advanced Materials

Graphene / 2D Materials Landscape

A cited snapshot of where the field is actually active, which institutions lead it, and which work merits deeper review before a technical bet.

Topic trendsLeading institutionsSource linked
Battery & Energy

Solid-State Battery Materials

A cited public-record landscape for locating research momentum, visible institutions, technical themes, and the papers worth opening first.

Research momentumInstitution scanCited papers
Investor Diligence

Geographic Atrophy Diligence Brief

A four-page decision packet that turns a broad question into an auditable starting point: activity, leaders, institutions, topics, and direct source links.

4 pagesCurrent recordsDirect citations
Investor Diligence

CRISPR-Enabled CAR-T Cell Therapy

A research-leadership and momentum packet for scoping an emerging platform area without treating publication volume as a commercial conclusion.

600 records4 pagesSource-limited
Life Sciences

Allogeneic iPSC Cell Therapy

A cited sample showing the research and institution signals a small team can use to frame deeper diligence on a platform bet.

270 records4 pagesCitations

Each packet is a starting point for a defined competitive question, not a claim of exhaustive coverage or a substitute for your own domain judgment. We build these for any market, technology, competitor set, or region.

Pricing

Project-based, priced against the analyst you cannot afford to hire.

Every engagement starts with a free cited sample so you can check the evidence before you commit. Prices are starting points; the scope — depth, sources, competitor set, cadence — sets the quote.

Start here — free

Evidence Sample

$0

One decision, one page, fully cited. We do the first-pass public-record work for a live question your team is facing right now.

Competitor Claim Audit

$299

One competitor, one set of public claims, tested against the record. Supported, overstated, or missing context — with every figure linked.

Investor Diligence Packet

from $5,000

Multi-source diligence on a company or sector for a major decision. Custom scope, quoted to the work, built to hold up in an investment committee.

Ongoing

Monthly Competitive Evidence Monitor

$600/month

Continuous coverage of funding, standards, policy, contracts and competitor movement in your category. Includes the Regulatory Window Monitor. Available after a first engagement.

The headcount math

Pay for the evidence, not the headcount.

OptionPublished hourly benchmarkIllustrative 5-hour allocation
External research support (contract analyst)$100 to $400 per hour$500 to $2,000
Tensorust Competitor Claim AuditFlat price$299

The five-hour figure is a simple staffing illustration, not a consultant quote or a claim that every manual assignment takes five hours. NIH's life-sciences guide lists $100 to $200 per hour for foundational data collection and research support, and $200 to $400 for mid-level consultants. A separate medical-communications guide lists medical-strategy contractors at $130 to $160 per hour. These are life-sciences benchmarks; rates in other sectors vary by scope, seniority and geography. NIH SEED rate guide · EPM Scientific medical-communications guide

Life-sciences teams can also buy a self-serve cited research-leader brief for $149, delivered automatically. Need something else? Ask for a custom quote.

Free evidence sample

Give us one competitive question and we will do the first-pass work for it, free.

Tell us the fight you are in. We will send back a one-page cited packet built from primary records, so you can judge the evidence before you spend anything.

By requesting, you are asking Tensorust to reply about this topic. If the form relay is unavailable, your email app will open with the request filled in.

Method & trust

Why you can put it in front of a buyer, a board, or an agency.
Federal contractsSEC filingsLobbying disclosuresFederal grantsPatentsStandards & rulemakingSafety & recallsVulnerability recordsScholarly literature

Full sources & provenance ›

Life sciences

Emerging biotech, medtech and pharma teams have a running start here.

Tensorust already carries cited research-leader maps across 59 therapeutic areas and a live preview you can run right now. Enter a topic and get research leaders, institutions and active subtopics in seconds.

Matthew Busel, founder of Tensorust
Built by Matthew Busel
Founder and engineer. I built the evidence engine and every tool on this site, in public. When you hire Tensorust you are not buying a seat in a platform — you are getting a real person who will go find the record, and every number traces to a source you can open yourself.
Connect on LinkedIn

Contact

Tell us who you are competing against.

Send the market, the competitor, or the decision in front of you. We will send back a short cited sample and scope what your team would spend in hours to assemble it by hand.

Or write directly: mattbusel@gmail.com

Your data stays yours. Tensorust reads only public government, corporate and scholarly records. We store no private data, and nothing you tell us about your market is sold, shared, or used to train anything.